Condition 101 About Prolymphocytic Leukemia

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Prolymphocytic Leukemia

Latest Advances On Prolymphocytic Leukemia

  • Condition: T Cell Prolymphocytic Leukemia (T-PLL)
  • Journal: Current hematologic malignancy reports
  • Treatment Used: Alemtuzumab Infusion Followed by Allogeneic Hematopoietic Stem Cell Transplantation (all-HSCT)
  • Number of Patients: 0
  • Published —
This study summarized current treatments for T cell prolymphocytic leukemia (T-PLL).
  • Condition: T-prolymphocytic leukemia
  • Journal: Annals of hematology
  • Treatment Used: Allogeneic hematopoietic cell transplantation
  • Number of Patients: 20
  • Published —
This study aimed to analyze the outcomes of allogeneic hematopoietic cell transplantation (HCT) among patients with T-prolymphocytic leukemia (T-PLL) to identify the potential clinical efficacy of allogeneic HCT.

Clinical Trials For Prolymphocytic Leukemia

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Radiation, Procedure, Biological
  • Participants: 60
  • Start Date: January 25, 2021
Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Patients With Hematological Malignancies Using a Treosulfan-Based Preparative Regimen